Who are SONIRE Therapeutics's investors?

SONIRE Therapeutics's investors include Fast Track Initiative, Sante Ventures.

How much funding has SONIRE Therapeutics raised?

SONIRE Therapeutics has disclosed $13.5M raised across 1 round.

SONIRE Therapeutics is headquartered in Palo Alto, US.

Palo Alto, US · Founded 2025 · Delaware corporation · 2 known investors

Paths you didn't know you had: your email and LinkedIn already hold routes to the SONIRE Therapeutics team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Tohru SatohNamed on SEC filing

Dennis McWilliamsBoard director

Koji Yasuda Board directorPrincipal at Fast Track Initiative

Jun OkamotoBoard director

Auriel AugustBoard director

How we know: a partner's Signal profile · Not right? Tell us

Form D private placements

$13.5M disclosed across 1 round · 2026

▶$13.5MraisedApr 2026 · 1 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Who are SONIRE Therapeutics's investors?: SONIRE Therapeutics's investors include Fast Track Initiative, Sante Ventures.
How much funding has SONIRE Therapeutics raised?: SONIRE Therapeutics has disclosed $13.5M raised across 1 round.
Where is SONIRE Therapeutics headquartered?: SONIRE Therapeutics is headquartered in Palo Alto, US.